{
    "eid": "2-s2.0-84999040240",
    "title": "Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [
        "ADAM10 metalloprotease",
        "Autoantibodies",
        "Colorectal carcinoma",
        "Immuno-proteomics",
        "Prognosis"
    ],
    "authors": [
        "Sheila Mar\u00eda \u00c1lvarez-Fern\u00e1ndez"
    ],
    "citedby-count": 11,
    "ref-count": 44,
    "ref-list": [
        "Cancer immunomics using autoantibody signatures for biomarker discovery",
        "Immunoproteomics to identify tumor-associated antigens eliciting humoral response",
        "Humoral response to cancer as a tool for biomarker discovery",
        "Assessment of the humoral immune response to cancer",
        "Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis",
        "Proteomics approaches to identify tumor antigen directed autoantibodies as cancer biomarkers",
        "Proteomics approaches towards antigen discovery and vaccine development",
        "Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets",
        "Autoantibody signature in human ductal pancreatic adenocarcinoma",
        "Circulating autoantibodies to phosphorylated \u03b1-enolase are a hallmark of pancreatic cancer",
        "\u03b1-enolase: A promising therapeutic and diagnostic tumor target",
        "Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer",
        "Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation",
        "Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells",
        "Serological immunoreactivity against colon cancer proteome varies upon disease progression",
        "Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer",
        "Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis",
        "Transl Res",
        "Emerging roles of ADAM and ADAMTS metalloproteinases in cancer",
        "A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells",
        "The functional maturation of a disintegrin and metalloproteinase (ADAM) 9, 10, and 17 requires processing at a newly identified proprotein convertase (PC) cleavage site",
        "The ADAM metalloproteinases",
        "The ADAM family of proteases",
        "Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases.",
        "Tetraspanins regulate ADAM10-mediated cleavage of TNF-and epidermal growth factor",
        "Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein",
        "Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10",
        "The TspanC8 subgroup of tetraspanins interacts with a disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression",
        "The \"A Disintegrin And Metalloproteases\" ADAM10 and ADAM17: Novel drug targets with therapeutic potential?",
        "The \"A Disintegrin And Metalloprotease\" (ADAM) family of sheddases: Physiological and cellular functions",
        "ADAMs, cell migration and cancer",
        null,
        "Expression of the Disintegrin Metalloprotease, ADAM-10, in Prostate Cancer and Its Regulation by Dihydrotestosterone, Insulin-Like Growth Factor I, and Epidermal Growth Factor in the Prostate Cancer Cell Model LNCaP",
        "Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma",
        "ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and \u03b2-catenin nuclear signalling",
        "Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer",
        "Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis",
        "ADAM10 as a target for anti-cancer therapy",
        "The ADAMs family of proteases: New biomarkers and therapeutic targets for cancer?",
        "Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor",
        "Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme",
        "An arginine stretch limits ADAM10 exit from the endoplasmic reticulum",
        "Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function",
        "Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Milan",
            "affilname": "IRCCS Ospedale San Raffaele",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Lund",
            "affilname": "Wallenberg Neuroscience Center",
            "affiliation-country": "Sweden"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Detroit",
            "affilname": "Wayne State University School of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Dresden",
            "affilname": "Technische Universit\u00e4t Dresden",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Milan",
            "affilname": "Universit\u00e0 Vita-Salute San Raffaele",
            "affiliation-country": "Italy"
        }
    ],
    "funding": [
        "National Cancer Institute",
        "National Cancer Institute"
    ]
}